Literature DB >> 6163816

T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells.

C D Tsoukas, R I Fox, S F Slovin, D A Carson, M Pellegrino, S Fong, J L Pasquali, S Ferrone, P Kung, J H Vaughan.   

Abstract

We have stimulated human peripheral blood lymphocytes in vitro with autologous EBV-infected or noninfected B cells. A cytotoxic response was obtained only when virally infected cells were used. The activity of the effector cells was restricted by the major histocompatibility complex and was directed against EBV-genome-bearing targets. The highest cytolytic response was obtained when lymphocytes of individuals previously exposed to the virus (EBV-VCA positive) were used. Lymphocytes of noninfected donors (EBV-VCA negative) gave a low response; the relative frequency of their effector cells was at least 4-fold lower. Lymphocytes of newborns did not respond. The cytotoxic activity was mediated by T lymphocytes of the cytotoxic/suppressor subset, as determined by cytofluorographic analysis and antibody plus complement-mediated lysis, using monoclonal antibodies to human lymphocyte surface antigen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163816

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells.

Authors:  L T Clement; M K Dagg; A Landay
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

Review 2.  The role of the human major histocompatibility complex in cytotoxic T-cell responses to virus-infected cells.

Authors:  W E Biddison
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

3.  HLA-B27, a dominant restricting element in antiviral responses?

Authors:  E Gomard; M Sitbon; A Toubert; B Bègue; J P Lévy
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Epstein-Barr virus and rheumatoid arthritis.

Authors:  H G Bluestein; F Hasler
Journal:  Surv Immunol Res       Date:  1984

5.  Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome.

Authors:  R I Fox; T C Adamson; S Fong; C A Robinson; E L Morgan; J A Robb; F V Howell
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors:  G R Nemerow; F C Jensen; N R Cooper
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

7.  Killing of measles virus-infected cells by human cytotoxic T cells.

Authors:  C J Lucas; W E Biddison; D L Nelson; S Shaw
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

8.  Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

Authors:  S F Slovin; D M Frisman; C D Tsoukas; I Royston; S M Baird; S B Wormsley; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

9.  Thoracic duct drainage in rheumatoid arthritis.

Authors:  J H Vaughan; R I Fox; R J Abresch; C D Tsoukas; J G Curd; D A Carson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

10.  Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.